PEREGRINE CAPITAL MANAGEMENT LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 132 filers reported holding NOVOCURE LTD in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$2,411,313
+99788.7%
40,095
+21.8%
0.07%
-7.9%
Q4 2022$2,414
-99.9%
32,912
-19.4%
0.08%
-24.0%
Q3 2022$3,102,000
+3.6%
40,830
-5.3%
0.10%
+11.1%
Q2 2022$2,995,000
-16.2%
43,098
-0.1%
0.09%
+5.9%
Q1 2022$3,573,000
+2.8%
43,125
-6.8%
0.08%
+21.4%
Q4 2021$3,474,000
-20.0%
46,264
+23.8%
0.07%
-22.2%
Q3 2021$4,341,000
-56.3%
37,366
-16.5%
0.09%
-49.4%
Q2 2021$9,926,000
+3.0%
44,747
-38.6%
0.18%
-0.6%
Q1 2021$9,633,000
-26.6%
72,880
-3.8%
0.18%
-28.1%
Q4 2020$13,116,000
-6.8%
75,797
-40.1%
0.25%
-33.2%
Q3 2020$14,080,000
+25.4%
126,496
-33.2%
0.37%
+16.9%
Q2 2020$11,232,000
+10.7%
189,404
+25.7%
0.32%
-12.4%
Q1 2020$10,147,000
-19.8%
150,689
+0.4%
0.36%
+13.0%
Q4 2019$12,652,000
+11.4%
150,135
-1.2%
0.32%
+4.2%
Q3 2019$11,362,000
-11.3%
151,942
-25.0%
0.31%
-2.2%
Q2 2019$12,811,000
+17.8%
202,617
-10.2%
0.32%
+16.2%
Q1 2019$10,872,000
-15.3%
225,705
-41.1%
0.27%
-24.9%
Q4 2018$12,837,000
-46.6%
383,421
-16.4%
0.36%
-36.4%
Q3 2018$24,028,000
-11.9%
458,559
-47.4%
0.57%
-16.4%
Q2 2018$27,263,000
+35.6%
871,029
-5.6%
0.68%
+38.4%
Q1 2018$20,110,000
+15.0%
922,468
+6.6%
0.49%
+19.7%
Q4 2017$17,487,000
+40.4%
865,671
+38.0%
0.41%
+37.5%
Q3 2017$12,455,000
-14.9%
627,476
-25.8%
0.30%
-18.1%
Q2 2017$14,636,000
+45.6%
846,036
-30.1%
0.36%
+42.6%
Q1 2017$10,051,000
+13.6%
1,210,934
+7.4%
0.26%
+11.3%
Q4 2016$8,851,000
+10.8%
1,127,486
+20.5%
0.23%
+10.6%
Q3 2016$7,988,000935,3080.21%
Other shareholders
NOVOCURE LTD shareholders Q1 2018
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders